Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares moved upwards by 38.8% to $0.62 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 65.2 million shares, making up 4427.4% of its average full-day volume over the last 100 days. The company's market cap stands at $6.2 million.
  • Allena Pharma (NASDAQ:ALNA) stock moved upwards by 30.49% to $0.25. As of 13:30 EST, Allena Pharma's stock is trading at a volume of 161.7 million, which is 775.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $22.3 million.
  • Omeros (NASDAQ:OMER) stock increased by 25.09% to $3.44. As of 13:30 EST, Omeros's stock is trading at a volume of 2.6 million, which is 240.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $215.7 million.
  • Clovis Oncology (NASDAQ:CLVS) stock increased by 20.66% to $2.17. The current volume of 38.8 million shares is 242.8% of Clovis Oncology's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $312.4 million.
  • Accolade (NASDAQ:ACCD) stock moved upwards by 19.86% to $8.87. Accolade's stock is trading at a volume of 2.5 million shares as of 13:30 EST. This is 128.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $631.6 million. As per the news, the Q1 earnings report came out yesterday.
  • Mereo BioPharma Group (NASDAQ:MREO) stock moved upwards by 19.19% to $1.33. Trading volume for Mereo BioPharma Group's stock is 2.9 million as of 13:30 EST. This is 59.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $156.1 million.

Losers

  • Talaris Therapeutics (NASDAQ:TALS) shares fell 47.0% to $2.39 during Friday's regular session. As of 13:30 EST, this security is trading at a volume of 2.1 million shares, making up 3532.4% of its average full-day volume over the last 100 days. The company's market cap stands at $99.0 million.
  • Agile Therapeutics (NASDAQ:AGRX) stock fell 42.65% to $0.67. The current volume of 42.8 million shares is 301.3% of Agile Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $3.0 million.
  • Akouos (NASDAQ:AKUS) stock decreased by 36.04% to $3.0. Akouos's stock is trading at a volume of 522.3K shares as of 13:30 EST. This is 140.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $103.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock decreased by 34.8% to $0.57. Trading volume for this security as of 13:30 EST is 3.1 million, which is 214.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $19.5 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock declined by 20.02% to $0.52. The current volume of 1.1 million shares is 202.3% of Dermata Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $4.7 million.
  • Encompass Health (NYSE:EHC) stock decreased by 17.92% to $46.01. As of 13:30 EST, Encompass Health's stock is trading at a volume of 785.2K, which is 101.3% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.